Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation
Jennifer Yeung(Thomas Jefferson University), Michael Holinstat(University of Michigan), Christopher J. Smyrniotis(University of California, Santa Cruz), Anton Simeonov(National Institutes of Health), Ajit Jadhav(National Institutes of Health), Jin Ren(Thomas Jefferson University), David J. Maloney(National Institutes of Health), Steven E. McKenzie(Thomas Jefferson University), Benjamin E. Tourdot(Cincinnati Children's Hospital Medical Center), Theodore R. Holman(University of California, Santa Cruz), Joanne Vesci(Thomas Jefferson University), Pilar Fernandez‐Perez(Thomas Jefferson University), Diane K. Luci(University of California, Santa Cruz)
Cited by 93
Related Papers
Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|391
Erratum: Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|327
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
|Cancer Cell|2018|255
Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
|Cell Discovery|2018|194
KDM5 histone demethylases repress immune response via suppression of STING
|PLoS Biology|2018|166